Direct-to-consumer Pricing
2 articles on Direct-to-consumer Pricing, researched and written by the Shotlee Editorial Team from primary sources.
Health Policy & Insurance
Medicare's New GLP-1 Weight-Loss Drug Program: What to Know
Medicare is launching a new pilot program to increase access to GLP-1 medications for weight loss, offering a $50 monthly copay for eligible beneficiaries. This marks a significant step in covering obesity as a medical condition.
9 min read
Weight Loss
Direct-to-Consumer Pricing: A New Era for GLP-1 Medications and Wellness?
The pharmaceutical landscape is shifting. Direct-to-consumer pricing for medications like GLP-1s is gaining traction. This could reshape how we access and afford treatments for weight loss and metabolic health. Learn how this might affect your wellness.
3 min read